SK72494A3 - Ipsapirone healing preparation - Google Patents

Ipsapirone healing preparation Download PDF

Info

Publication number
SK72494A3
SK72494A3 SK724-94A SK72494A SK72494A3 SK 72494 A3 SK72494 A3 SK 72494A3 SK 72494 A SK72494 A SK 72494A SK 72494 A3 SK72494 A3 SK 72494A3
Authority
SK
Slovakia
Prior art keywords
pellets
ipsapirone
diffusion
hours
release
Prior art date
Application number
SK724-94A
Other languages
English (en)
Slovak (sk)
Inventor
Peter Serno
Wolfgang Fischer
Roland Rupp
Mark Versavel
Ulrich Tenter
Gerhard Schmidt
Gunter Schollnhammer
Maria Ammen
Shinji Maegata
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of SK72494A3 publication Critical patent/SK72494A3/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
SK724-94A 1993-06-15 1994-06-14 Ipsapirone healing preparation SK72494A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4319760A DE4319760A1 (de) 1993-06-15 1993-06-15 Ipsapiron Arzneimittelzubereitung

Publications (1)

Publication Number Publication Date
SK72494A3 true SK72494A3 (en) 1995-04-12

Family

ID=6490360

Family Applications (1)

Application Number Title Priority Date Filing Date
SK724-94A SK72494A3 (en) 1993-06-15 1994-06-14 Ipsapirone healing preparation

Country Status (16)

Country Link
EP (1) EP0629402A1 (ko)
JP (1) JPH06345649A (ko)
KR (1) KR950000150A (ko)
CN (1) CN1099263A (ko)
AU (1) AU6345794A (ko)
CA (1) CA2125620A1 (ko)
CZ (1) CZ146494A3 (ko)
DE (1) DE4319760A1 (ko)
FI (1) FI942803A (ko)
HU (1) HUT70759A (ko)
IL (1) IL109993A0 (ko)
NO (1) NO942228L (ko)
NZ (1) NZ260732A (ko)
PL (1) PL303822A1 (ko)
SK (1) SK72494A3 (ko)
ZA (1) ZA944187B (ko)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9706089D0 (en) * 1997-03-24 1997-05-14 Scherer Ltd R P Pharmaceutical composition
OA11740A (en) * 1998-12-24 2005-05-13 Janssen Pharmaceutica Nv Controlled release galantamine composition.
WO2004103338A1 (en) * 2003-05-19 2004-12-02 Bioprogress Plc Adhesives and film modifying compositions
PL4062913T3 (pl) * 2020-09-02 2024-07-22 Beijing Biostar Pharmaceuticals Co., Ltd. Stały preparat doustny utidelonu

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0386440T3 (da) * 1989-02-11 1992-09-14 Bayer Ag Lægemidler med kontrolleret afgivelse af virksomt stof
DD297767A5 (de) * 1990-03-06 1992-01-23 Bayer Aktiengesellschaft,De Arzneimittel mit kontrollierter wirkstoffabgabe
JPH04360826A (ja) * 1991-06-07 1992-12-14 Bayer Yakuhin Kk 放出制御製剤

Also Published As

Publication number Publication date
NZ260732A (en) 1996-02-27
JPH06345649A (ja) 1994-12-20
FI942803A0 (fi) 1994-06-13
FI942803A (fi) 1994-12-16
EP0629402A1 (de) 1994-12-21
CN1099263A (zh) 1995-03-01
PL303822A1 (en) 1995-01-09
CZ146494A3 (en) 1995-01-18
KR950000150A (ko) 1995-01-03
ZA944187B (en) 1995-02-08
AU6345794A (en) 1994-12-22
CA2125620A1 (en) 1994-12-16
NO942228L (no) 1994-12-16
NO942228D0 (no) 1994-06-14
HUT70759A (en) 1995-10-30
IL109993A0 (en) 1994-10-07
DE4319760A1 (de) 1994-12-22
HU9401771D0 (en) 1994-09-28

Similar Documents

Publication Publication Date Title
EP0660705B1 (en) Advanced drug delivery system and method of treating psychiatric, neurological and other disorders with carbamazepine
EP2289492B1 (en) Naltrexone hydrochloride compositions
US6312728B1 (en) Sustained release pharmaceutical preparation
US5370880A (en) Pharmaceutical formulations containing acrivastine
US4806361A (en) Medicaments in sustained release unit dose form
US20060115525A1 (en) Pharmaceutical compositions
HU219462B (hu) Asztemizolt és pszeudoefedrint tartalmazó, nyújtott hatású, filmbevonatos tabletták
CN108066319B (zh) 一种枸橼酸托法替布肠溶缓释微丸及其制备方法
US20030157169A1 (en) Controlled release dosage form of [R-(Z)]-alpha-(methoxyimino)-alpha-(1-azabicyclo[2.2.2]oct-3-yl)acetonitrile monohydrochloride
WO2007097770A1 (en) Metoprolol succinate e.r. tablets and methods for their preparation
NZ522250A (en) Sustained release beadlets containing stavudine stabilised by magnesium stearate
EP1154762B1 (en) Pharmaceutical capsule compositions containing loratadine and pseudoephedrine
AU724086B2 (en) Controlled release dosage form of (R-(Z))-alpha- (methoxyimino)-alpha-(1-azabicyclo(2.2.2)oct-3-yl) acetonitrile monohydrochloride
US20090220593A1 (en) Extended release dosage forms of quetiapine
US10953022B2 (en) Modified release doxycycline composition
SK72494A3 (en) Ipsapirone healing preparation
FI95776B (fi) Menetelmä tehoainetta alhaisen annoksen kontrolloidusti vapauttavien aspiriinitablettien valmistamiseksi
KR100505899B1 (ko) 로라타딘과 슈도에페드린을 함유한 캅셀제 조성물
JP2018513138A (ja) ミューオピオイド受容体アンタゴニストとオピオイド剤との組み合わせ剤形
KR20030076634A (ko) 의약 조성물
JPH0797330A (ja) 経口コレステロール低下剤
KR20160127405A (ko) 리바스티그민 함유 서방출 의약조성물
CA3238807A1 (en) Controlled release formulations of flavoxate and process for preparation thereof
KR20150137272A (ko) 안정한 프레가발린 제어 방출성 서방형 제약 조성물 및 그 제조방법
KR20080095873A (ko) 이미다졸릴알킬-피리딘의 안정한 제제